Skip to content

Expression XVIII - Fear of Cancer versus Fear of Crisis – International Patient Survey on the Influence of Crisis on Cancer Patients

Expression XVIII - Fear of Cancer versus Fear of Crisis – International Patient Survey on the Influence of Crisis on Cancer Patients - Exp. XVIII

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037209
Enrollment
250
Registered
2025-06-17
Start date
2025-06-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50 C51 C52 C53 C54 C55 C56 C57 D39

Interventions

Group 1: The survey is open to all female patients diagnosed with gynecological cancer, including breast cancer, regardless of the stage of disease or treatments received. It focuses on aspects of sup

Sponsors

NOGGO e.V. Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of a gynecological-oncological tumor disease, currently or in the past

Exclusion criteria

Exclusion criteria: Women under the age of 18

Design outcomes

Primary

MeasureTime frame
The study investigates the association between fear of cancer recurrence and fear of future life crises. Both parameters are assessed once using standardized questionnaires.

Secondary

MeasureTime frame
Generalized anxiety disorder is recorded using the GAD-7 scale, the extent of fear of social crises (e.g. pandemics, wars, climate change) using a specially developed scale, information behavior regarding current crises and access to psycho-oncological care. These secondary endpoints serve to investigate the relationships between psychological stress, external crisis perception and supportive measures in cancer patients.

Countries

Germany

Contacts

Public ContactSedra Al Tarris

Klinik für Gynäkologie, Charité Campus Virchow, Charité - Universitätsmedizin Berlin

sedra.al-tarris@charite.de+49 30 403686530

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026